Comprehensive proteome profiling of platelet identified a protein profile predictive of responses to an antiplatelet agent sarpogrelate

Hangyeore Lee, Sehyun Chae, Jisook Park, Jingi Bae, Eun Bi Go, Su Jin Kim, Hokeun Kim, Daehee Hwang, Sang-Won Lee, Soo Youn Lee

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Sarpogrelate is an antiplatelet agent widely used to treat arterial occlusive diseases. Evaluation of platelet aggregation is essential to monitor therapeutic effects of sarpogrelate. Currently, no molecular signatures are available to evaluate platelet aggregation. Here, we performed comprehensive proteome profiling of platelets collected from 18 subjects before and after sarpogrelate administration using LC-MS/MS analysis coupled with extensive fractionation. Of 5423 proteins detected, we identified 499 proteins affected by sarpogrelate and found that they strongly represented cellular processes related to platelet activation and aggregation, including cell activation, coagulation, and vesicle-mediated transports. Based on the network model of the proteins involved in these processes, we selected three proteins (cut-like homeobox 1; coagulation factor XIII, B polypeptide; and peptidylprolyl isomerase D) that reflect the platelet aggregation-related processes after confirming their alterations by sarpogrelate in independent samples using Western blotting. Our proteomic approach provided a protein profile predictive of therapeutic effects of sarpogrelate.

Original languageEnglish
Pages (from-to)3461-3472
Number of pages12
JournalMolecular and Cellular Proteomics
Volume15
Issue number11
DOIs
Publication statusPublished - 2016 Nov 1

Fingerprint

Platelet Aggregation Inhibitors
Proteome
Platelets
Blood Platelets
Platelet Aggregation
Agglomeration
Proteins
Therapeutic Uses
Chemical activation
Peptidylprolyl Isomerase
Factor XIII
Transport Vesicles
Arterial Occlusive Diseases
Homeobox Genes
Platelet Activation
Fractionation
Coagulation
Proteomics
sarpogrelate
Western Blotting

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry
  • Molecular Biology

Cite this

Comprehensive proteome profiling of platelet identified a protein profile predictive of responses to an antiplatelet agent sarpogrelate. / Lee, Hangyeore; Chae, Sehyun; Park, Jisook; Bae, Jingi; Go, Eun Bi; Kim, Su Jin; Kim, Hokeun; Hwang, Daehee; Lee, Sang-Won; Lee, Soo Youn.

In: Molecular and Cellular Proteomics, Vol. 15, No. 11, 01.11.2016, p. 3461-3472.

Research output: Contribution to journalArticle

Lee, Hangyeore ; Chae, Sehyun ; Park, Jisook ; Bae, Jingi ; Go, Eun Bi ; Kim, Su Jin ; Kim, Hokeun ; Hwang, Daehee ; Lee, Sang-Won ; Lee, Soo Youn. / Comprehensive proteome profiling of platelet identified a protein profile predictive of responses to an antiplatelet agent sarpogrelate. In: Molecular and Cellular Proteomics. 2016 ; Vol. 15, No. 11. pp. 3461-3472.
@article{5243ad92a8244024b3dd9e4f47227259,
title = "Comprehensive proteome profiling of platelet identified a protein profile predictive of responses to an antiplatelet agent sarpogrelate",
abstract = "Sarpogrelate is an antiplatelet agent widely used to treat arterial occlusive diseases. Evaluation of platelet aggregation is essential to monitor therapeutic effects of sarpogrelate. Currently, no molecular signatures are available to evaluate platelet aggregation. Here, we performed comprehensive proteome profiling of platelets collected from 18 subjects before and after sarpogrelate administration using LC-MS/MS analysis coupled with extensive fractionation. Of 5423 proteins detected, we identified 499 proteins affected by sarpogrelate and found that they strongly represented cellular processes related to platelet activation and aggregation, including cell activation, coagulation, and vesicle-mediated transports. Based on the network model of the proteins involved in these processes, we selected three proteins (cut-like homeobox 1; coagulation factor XIII, B polypeptide; and peptidylprolyl isomerase D) that reflect the platelet aggregation-related processes after confirming their alterations by sarpogrelate in independent samples using Western blotting. Our proteomic approach provided a protein profile predictive of therapeutic effects of sarpogrelate.",
author = "Hangyeore Lee and Sehyun Chae and Jisook Park and Jingi Bae and Go, {Eun Bi} and Kim, {Su Jin} and Hokeun Kim and Daehee Hwang and Sang-Won Lee and Lee, {Soo Youn}",
year = "2016",
month = "11",
day = "1",
doi = "10.1074/mcp.M116.059154",
language = "English",
volume = "15",
pages = "3461--3472",
journal = "The BMJ",
issn = "0730-6512",
publisher = "Kluwer Academic Publishers",
number = "11",

}

TY - JOUR

T1 - Comprehensive proteome profiling of platelet identified a protein profile predictive of responses to an antiplatelet agent sarpogrelate

AU - Lee, Hangyeore

AU - Chae, Sehyun

AU - Park, Jisook

AU - Bae, Jingi

AU - Go, Eun Bi

AU - Kim, Su Jin

AU - Kim, Hokeun

AU - Hwang, Daehee

AU - Lee, Sang-Won

AU - Lee, Soo Youn

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Sarpogrelate is an antiplatelet agent widely used to treat arterial occlusive diseases. Evaluation of platelet aggregation is essential to monitor therapeutic effects of sarpogrelate. Currently, no molecular signatures are available to evaluate platelet aggregation. Here, we performed comprehensive proteome profiling of platelets collected from 18 subjects before and after sarpogrelate administration using LC-MS/MS analysis coupled with extensive fractionation. Of 5423 proteins detected, we identified 499 proteins affected by sarpogrelate and found that they strongly represented cellular processes related to platelet activation and aggregation, including cell activation, coagulation, and vesicle-mediated transports. Based on the network model of the proteins involved in these processes, we selected three proteins (cut-like homeobox 1; coagulation factor XIII, B polypeptide; and peptidylprolyl isomerase D) that reflect the platelet aggregation-related processes after confirming their alterations by sarpogrelate in independent samples using Western blotting. Our proteomic approach provided a protein profile predictive of therapeutic effects of sarpogrelate.

AB - Sarpogrelate is an antiplatelet agent widely used to treat arterial occlusive diseases. Evaluation of platelet aggregation is essential to monitor therapeutic effects of sarpogrelate. Currently, no molecular signatures are available to evaluate platelet aggregation. Here, we performed comprehensive proteome profiling of platelets collected from 18 subjects before and after sarpogrelate administration using LC-MS/MS analysis coupled with extensive fractionation. Of 5423 proteins detected, we identified 499 proteins affected by sarpogrelate and found that they strongly represented cellular processes related to platelet activation and aggregation, including cell activation, coagulation, and vesicle-mediated transports. Based on the network model of the proteins involved in these processes, we selected three proteins (cut-like homeobox 1; coagulation factor XIII, B polypeptide; and peptidylprolyl isomerase D) that reflect the platelet aggregation-related processes after confirming their alterations by sarpogrelate in independent samples using Western blotting. Our proteomic approach provided a protein profile predictive of therapeutic effects of sarpogrelate.

UR - http://www.scopus.com/inward/record.url?scp=84995527575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995527575&partnerID=8YFLogxK

U2 - 10.1074/mcp.M116.059154

DO - 10.1074/mcp.M116.059154

M3 - Article

C2 - 27601597

AN - SCOPUS:84995527575

VL - 15

SP - 3461

EP - 3472

JO - The BMJ

JF - The BMJ

SN - 0730-6512

IS - 11

ER -